Skip to Main Content

Author Details

Arie Perry
University of California san francisco
1984
441
93
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36227281Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.Neuro Oncol2023
35657335Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.Neuro Oncol2023
36227281Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.Neuro Oncol2023
35678633Molecular characterization of metachronous atypical teratoid rhabdoid tumors occurring in a young man 15 years apart.Pediatr Blood Cancer2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36897259Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.Blood Adv2023
36826690Sarcomatous Transformation of a Medically Treated Lactotroph Pituitary Neuroendocrine Tumor?Endocr Pathol2023
37268858Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.Endocr Pathol2023
37436963Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.Neuro Oncol2023
36993741Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Res Sq2023
36543154Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.Am J Surg Pathol2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
37503127NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.bioRxiv2023
37487571Cavernous sinus hemangioma: Histopathological spectrum of 8 cases.J Neuropathol Exp Neurol2023
37546798Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis.Res Sq2023
37292686Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.Res Sq2023
36723772Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.Acta Neuropathol2023
37487571Cavernous sinus hemangioma: Histopathological spectrum of 8 cases.J Neuropathol Exp Neurol2023
37546798Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis.Res Sq2023
37503127NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.bioRxiv2023
35678633Molecular characterization of metachronous atypical teratoid rhabdoid tumors occurring in a young man 15 years apart.Pediatr Blood Cancer2023
35657335Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.Neuro Oncol2023
37292686Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.Res Sq2023
36993741Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Res Sq2023
37436963Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.Neuro Oncol2023
37268858Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.Endocr Pathol2023
36723772Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.Acta Neuropathol2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36543154Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.Am J Surg Pathol2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36826690Sarcomatous Transformation of a Medically Treated Lactotroph Pituitary Neuroendocrine Tumor?Endocr Pathol2023
36897259Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.Blood Adv2023
34821426Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.Brain Pathol2022
35395677Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.Neuro Oncol2022
35703914Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma.J Neuropathol Exp Neurol2022
35511927CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma.Clin Cancer Res2022
35759011Intratumor and informatic heterogeneity influence meningioma molecular classification.Acta Neuropathol2022
35945463Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.Acta Neuropathol2022
35689747Immature PIT1-Lineage Pituitary Neuroendocrine Tumor: a 17-Year-Old Male with Pathogenic AIP Mutation.Endocr Pathol2022
36130567NTRK3 gene fusion in an adult ganglioglioma: illustrative case.J Neurosurg Case Lessons2022
36201019Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.Acta Neuropathol2022
35475853Orbital Rosai-Dorfman Disease Presenting as Optic Neuritis.J Neuroophthalmol2022
35534562Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.Nat Genet2022
35291028Overview of the 2022 WHO Classification of Pituitary Tumors.Endocr Pathol2022
34910220Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma.Acta Neuropathol2022
35213084Molecular neuropathology of brain-invasive meningiomas.Brain Pathol2022
35175291Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas.Arch Pathol Lab Med2022
35157770A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.Blood Adv2022
34825267EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma.Acta Neuropathol2022
34821426Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.Brain Pathol2022
  • 1 - 50 of 882

Recommended Authors

Felix Behling
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2015
Number of shared co-authors 6
Kentaro Ohara
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 0
Nitin R Wadhwani
Feinberg School of Medicine, Northwestern University
Career Start Year 2011
Number of shared co-authors 6
Prajwal Rajappa
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 2
Delphine Guillemot
Institut Curie Hospital
Career Start Year 2010
Number of shared co-authors 10
Ashley Margol
Children's Hospital Los Angeles
Career Start Year 2010
Number of shared co-authors 39
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 83
Melitta Kitzwoegerer
Karl Landsteiner University of Health Sciences
Career Start Year 2007
Number of shared co-authors 3
Cristiane M Ida
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 8
David J Pisapia
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year 2004
Number of shared co-authors 7
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 19
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Naoki Shinojima
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 2
Piergiorgio Modena
S. Anna General Hospital
Career Start Year 2000
Number of shared co-authors 41
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 10
Jo??lle Lacombe
centre hospitalier Sainte-Anne
Career Start Year 1999
Number of shared co-authors 17
Jaishri O Blakeley
Johns Hopkins University
Career Start Year 1998
Number of shared co-authors 29
Jaume Mora
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 100
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 37
Yeon-Lim Suh
Samsung Medical Center, Sungkyunkwan University College of Medicine
Career Start Year 1994
Number of shared co-authors 0
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 11
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 18
Alexander O Vortmeyer
Indiana University School of Medicine
Career Start Year 1988
Number of shared co-authors 7
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 25
Takanori Hirose
Hyogo Cancer Center
Career Start Year 1984
Number of shared co-authors 5
James T Rutka
Hospital for Sick Children
Career Start Year 1984
Number of shared co-authors 95
Maria Luisa Garr??
DOPO Clinic and Neuroncology Unit, IRCCS Istituto Giannina Gaslini (IGG)
Career Start Year 1983
Number of shared co-authors 71
Scott R VandenBerg
University of California san francisco
Career Start Year 1975
Number of shared co-authors 68
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 29
Boleslaw Lach
McMaster University
Career Start Year 1970
Number of shared co-authors 64

Collaborators

David A Solomon
University of California san francisco
Co-authored papers 71
Joanna J Phillips
University of California san francisco
Co-authored papers 51
David H Gutmann
Co-authored papers 50
Mitchel S Berger
University of California san francisco
Co-authored papers 35
Andreas von Deimling
Co-authored papers 30
David R Raleigh
University of California san francisco
Co-authored papers 26
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 24
Guido Reifenberger
Heinrich Heine University
Co-authored papers 24
Calixto-Hope G Lucas
University of California San Francisco
Co-authored papers 24
Daniel J Brat
Co-authored papers 24
Caterina Giannini
Mayo Clinic
Co-authored papers 22
Nancy Ann Oberheim Bush
University of California san francisco
Co-authored papers 21
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 20
Nalin Gupta
Co-authored papers 20
Kenneth Aldape
National Cancer Institute
Co-authored papers 20
David W Ellison
St. Jude Children's Research Hospital
Co-authored papers 19
Michael W McDermott
University of California san francisco
Co-authored papers 18
Peter C Burger
Co-authored papers 18
Nicholas Butowski
University of California san francisco
Co-authored papers 18
David N Louis
Co-authored papers 18
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 17
David Samuel
Co-authored papers 17
Fausto J Rodriguez
University of California Los Angeles
Co-authored papers 16
Stephen T Magill
Feinberg School of Medicine, Northwestern University
Co-authored papers 16
Steve E Braunstein
University of California san francisco
Co-authored papers 15
Javier E Villanueva-Meyer
University of California san francisco
Co-authored papers 15
David Capper
Charite University Medicine Berlin
Co-authored papers 15
Sabine Mueller
University Children's Hospital Zurich
Co-authored papers 14
Anuradha Banerjee
Co-authored papers 14
Annette M Molinaro
Co-authored papers 14
Release 1.2